Zydus gets US FDA final nod for Febuxostat tablets for treating high uric acid

According to the statement from Zydus, Febuxostat tablets are indicated to lower hyperuricemia (high uric acid in the blood) in patients with gout who have been treated with allopurinol that did not work well or cannot be treated with allopurinol.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/pfFxLe1
via IFTTT